Project Grant R00HG013661
- Federal Grant Award Summary Yale University received a $248,823 Project Grant from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), effective May 1, 2026 through April 30, 2029. This award supports the development of integrative machine learning models to elucidate the functional consequences of nuclear DNA organization on gene regulation and human health. The project delivers three primary research products: (1) novel deep learning...
- Federal Project Grant Award Summary Baylor College of Medicine received a $719,909 Project Grant from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), awarded March 13, 2026, with an ultimate completion date of February 28, 2030. The award funds development of a novel, user-friendly local graph genome approach to characterize medically relevant complex regions of the human genome, specifically targeting genes such as LPA...
- Federal Grant Award Summary The National Human Genome Research Institute (NHGRI) awarded a $780,113 Project Grant to the University of California, Los Angeles (UCLA) Office of Research Administration, effective September 1, 2025, through August 31, 2029, under the Human Genome Research program (CFDA 93.172). This award supports the development of simulation, modeling, and estimation methods to address critical gaps in genetic association studies. Specifically, the project will create a...
- Federal Project Grant Award Summary New York University School of Medicine received a $466,125 Project Grant from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), awarded on May 18, 2026, with a completion date of April 30, 2028. The award funds a cross-species analysis of regulatory genomic function utilizing synthetic regulatory genomics and the BIG-IN (in situ) genome engineering technology platform. The research will characterize the...
- Federal Project Grant Award Summary The National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172) awarded The Leland Stanford Junior University $721,450 in federal funding effective March 1, 2026 through February 28, 2030 to develop and deploy computational and experimental tools for mapping enhancer-gene regulatory interactions across human cell types. The award supports three primary deliverables: (1) optimization and deployment of a computational...
- Federal Grant Award Summary Yale University received a $2.72 million Project Grant award from the National Institute of Environmental Health Sciences under the Medical Library Assistance program (CFDA 93.879) on September 17, 2025, with completion scheduled for August 31, 2029. The project, titled "Supervised Weighted Distances: Patient Similarity to Explain Clinical AI Models," develops algorithms and software tools to enhance the interpretability of complex predictive clinical...
- Federal Project Grant Award Summary Brigham & Women's Hospital Inc. received a $240,647 Project Grant from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), awarded September 1, 2025, with a completion date of August 31, 2027. The project will develop and optimize deep learning methods to resolve uncertain variant classifications in genomic medicine by leveraging over 1.1 million plaintext clinical diagnostic reports curated in...
- Federal Grant Award Summary The National Human Genome Research Institute (NHGRI) awarded Massachusetts General Hospital $3.29M under the Human Genome Research program (CFDA 93.172) on September 17, 2025, for a project addressing computational and statistical methodological gaps in genome-wide association studies (GWAS) of disease course over time. The award funds research through August 31, 2029, to develop scalable computational tools and statistical methods that leverage longitudinal...
- Federal Project Grant Award Summary The National Human Genome Research Institute (NHGRI) awarded the University of Washington a $2.22 million Project Grant under the Human Genome Research program (CFDA 93.172) on September 10, 2025, with completion targeted for August 31, 2029. The project, titled "Sequence-to-Function Models for Mechanistic Investigations of Personal Genomes," develops advanced deep learning models to predict gene expression consequences directly from DNA sequences....
- Federal Grant Award Summary The National Human Genome Research Institute (NHGRI) awarded a $2.8 million Project Grant to The Washington University (Office of Sponsored Research Services) effective September 1, 2025, through August 31, 2029, under the Human Genome Research program (CFDA 93.172). This award supports the development and implementation of a high-throughput, genome-integrated reporter gene system designed to systematically measure enhancer activities at multiple fixed distances...
Yale University received a $248,997 Project Grant from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), effective September 1, 2025, through August 31, 2028. The award supports research directed by Dr. Qiao Liu to develop and advance genomic Large Language Models (LLMs) as tools for interpreting how genetic variants affect phenotypic outcomes. The primary deliverable centers on creating core genomic LLM technologies with enhanced biological model interpretation capabilities, with particular emphasis on understanding how transcription factors bind to DNA recognition sites in genomic regulatory regions and control gene transcription in context-specific manners. The funded research extends the genomic LLM platform into two applied research areas: imaging genetics studies that employ imaging traits as phenotypes analogous to genome-wide association studies, and development of machine learning approaches for Alzheimer's disease diagnosis. By bridging genetic variants and radiometric phenotypes through advanced language modeling techniques, the project addresses a fundamental challenge in modern genomics—namely, the difficulty in establishing direct biological relevance between genome-wide association study signals and actual phenotypic consequences. The three-year project is positioned to advance understanding of complex regulatory mechanisms in gene regulation and support translational applications in disease diagnosis and precision medicine.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $249.0k | 9/26/25 |